Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 107

1.

The transcriptome of the Didelphis virginiana opossum kidney OK proximal tubule cell line.

Eshbach ML, Sethi R, Avula R, Lamb J, Hollingshead DJ, Finegold DN, Locker JD, Chandran UR, Weisz OA.

Am J Physiol Renal Physiol. 2017 Sep 1;313(3):F585-F595. doi: 10.1152/ajprenal.00228.2017. Epub 2017 Jun 14.

PMID:
28615248
2.

Neurometabolic Disorders: Potentially Treatable Abnormalities in Patients With Treatment-Refractory Depression and Suicidal Behavior.

Pan LA, Martin P, Zimmer T, Segreti AM, Kassiff S, McKain BW, Baca CA, Rengasamy M, Hyland K, Walano N, Steinfeld R, Hughes M, Dobrowolski SK, Pasquino M, Diler R, Perel J, Finegold DN, Peters DG, Naviaux RK, Brent DA, Vockley J.

Am J Psychiatry. 2017 Jan 1;174(1):42-50. doi: 10.1176/appi.ajp.2016.15111500. Epub 2016 Aug 13.

PMID:
27523499
3.

Treatment of Fabry's Disease with the Pharmacologic Chaperone Migalastat.

Germain DP, Hughes DA, Nicholls K, Bichet DG, Giugliani R, Wilcox WR, Feliciani C, Shankar SP, Ezgu F, Amartino H, Bratkovic D, Feldt-Rasmussen U, Nedd K, Sharaf El Din U, Lourenco CM, Banikazemi M, Charrow J, Dasouki M, Finegold D, Giraldo P, Goker-Alpan O, Longo N, Scott CR, Torra R, Tuffaha A, Jovanovic A, Waldek S, Packman S, Ludington E, Viereck C, Kirk J, Yu J, Benjamin ER, Johnson F, Lockhart DJ, Skuban N, Castelli J, Barth J, Barlow C, Schiffmann R.

N Engl J Med. 2016 Aug 11;375(6):545-55. doi: 10.1056/NEJMoa1510198.

4.

Rapid progression and mortality of lysosomal acid lipase deficiency presenting in infants.

Jones SA, Valayannopoulos V, Schneider E, Eckert S, Banikazemi M, Bialer M, Cederbaum S, Chan A, Dhawan A, Di Rocco M, Domm J, Enns GM, Finegold D, Gargus JJ, Guardamagna O, Hendriksz C, Mahmoud IG, Raiman J, Selim LA, Whitley CB, Zaki O, Quinn AG.

Genet Med. 2016 May;18(5):452-8. doi: 10.1038/gim.2015.108. Epub 2015 Aug 27.

5.

Evaluation of disease burden and response to treatment in adults with type 1 Gaucher disease using a validated disease severity scoring system (DS3).

Weinreb NJ, Finegold DN, Feingold E, Zeng Z, Rosenbloom BE, Shankar SP, Amato D.

Orphanet J Rare Dis. 2015 May 22;10:64. doi: 10.1186/s13023-015-0280-3.

6.

Altered dynamics of a lipid raft associated protein in a kidney model of Fabry disease.

Labilloy A, Youker RT, Bruns JR, Kukic I, Kiselyov K, Halfter W, Finegold D, do Monte SJ, Weisz OA.

Mol Genet Metab. 2014 Feb;111(2):184-92. doi: 10.1016/j.ymgme.2013.10.010. Epub 2013 Oct 19.

7.

Lymphedema prevention and early intervention: a worthy goal.

Soran A, Finegold DN, Brufsky A.

Oncology (Williston Park). 2012 Mar;26(3):249, 254, 256. No abstract available.

8.

Connexin 47 mutations increase risk for secondary lymphedema following breast cancer treatment.

Finegold DN, Baty CJ, Knickelbein KZ, Perschke S, Noon SE, Campbell D, Karlsson JM, Huang D, Kimak MA, Lawrence EC, Feingold E, Meriney SD, Brufsky AM, Ferrell RE.

Clin Cancer Res. 2012 Apr 15;18(8):2382-90. doi: 10.1158/1078-0432.CCR-11-2303. Epub 2012 Feb 20.

9.

Infant with unusual food reactions.

Ruffner MA, Finegold DN, MacGinnitie AJ.

Acta Paediatr. 2011 Oct;100(10):1289, 1394-5. doi: 10.1111/j.1651-2227.2011.02316.x. No abstract available.

PMID:
21916981
10.

The effects of testosterone on craniosynostotic calvarial cells: a test of the gene/environmental model of craniofacial anomalies.

Cray JJ Jr, Durham EL, Smalley MA, Finegold DN, Siegel MI, Losee JE, Mooney MP, Cooper GM.

Orthod Craniofac Res. 2011 Aug;14(3):149-55. doi: 10.1111/j.1601-6343.2011.01520.x. Epub 2011 Jul 14.

PMID:
21771269
11.

Phase I (safety) study of autologous tolerogenic dendritic cells in type 1 diabetic patients.

Giannoukakis N, Phillips B, Finegold D, Harnaha J, Trucco M.

Diabetes Care. 2011 Sep;34(9):2026-32. doi: 10.2337/dc11-0472. Epub 2011 Jun 16.

12.

Markedly elevated serum transaminases in glycogen storage disease type III.

Karwowski C, Galambos C, Finegold D, Shneider BL.

J Pediatr Gastroenterol Nutr. 2011 May;52(5):621-3. doi: 10.1097/MPG.0b013e31820e6a55. No abstract available.

13.

Sudden death in medium chain acyl-coenzyme a dehydrogenase deficiency (MCADD) despite newborn screening.

Yusupov R, Finegold DN, Naylor EW, Sahai I, Waisbren S, Levy HL.

Mol Genet Metab. 2010 Sep;101(1):33-9. doi: 10.1016/j.ymgme.2010.05.007. Epub 2010 Jun 9.

PMID:
20580581
14.

GJC2 missense mutations cause human lymphedema.

Ferrell RE, Baty CJ, Kimak MA, Karlsson JM, Lawrence EC, Franke-Snyder M, Meriney SD, Feingold E, Finegold DN.

Am J Hum Genet. 2010 Jun 11;86(6):943-8. doi: 10.1016/j.ajhg.2010.04.010. Epub 2010 May 27.

15.

Effects of flutamide therapy on craniofacial growth and development in a model of craniosynostosis.

Cray J Jr, Burrows AM, Vecchione L, Lensie E, Decesare GE, Campbell A, Finegold DN, Losee JE, Siegel MI, Cooper GM, Mooney MP.

J Craniofac Surg. 2010 May;21(3):711-8. doi: 10.1097/SCS.0b013e3181d80a36.

PMID:
20485034
16.

Newborn screening for galactosemia: a review of 5 years of data and audit of a revised reporting approach.

Freer DE, Ficicioglu C, Finegold D.

Clin Chem. 2010 Mar;56(3):437-44. doi: 10.1373/clinchem.2009.135947. Epub 2010 Jan 14.

17.

Population-based Tay-Sachs screening among Ashkenazi Jewish young adults in the 21st century: Hexosaminidase A enzyme assay is essential for accurate testing.

Schneider A, Nakagawa S, Keep R, Dorsainville D, Charrow J, Aleck K, Hoffman J, Minkoff S, Finegold D, Sun W, Spencer A, Lebow J, Zhan J, Apfelroth S, Schreiber-Agus N, Gross S.

Am J Med Genet A. 2009 Nov;149A(11):2444-7. doi: 10.1002/ajmg.a.33085.

PMID:
19876898
18.

The influence of macrophage migration inhibitory factor gene polymorphisms on outcome from community-acquired pneumonia.

Yende S, Angus DC, Kong L, Kellum JA, Weissfeld L, Ferrell R, Finegold D, Carter M, Leng L, Peng ZY, Bucala R.

FASEB J. 2009 Aug;23(8):2403-11. doi: 10.1096/fj.09-129445. Epub 2009 Apr 3.

19.

Evidence supporting a role for the calcium-sensing receptor in Alzheimer disease.

Conley YP, Mukherjee A, Kammerer C, DeKosky ST, Kamboh MI, Finegold DN, Ferrell RE.

Am J Med Genet B Neuropsychiatr Genet. 2009 Jul 5;150B(5):703-9. doi: 10.1002/ajmg.b.30896.

20.

Candidate gene analysis in primary lymphedema.

Ferrell RE, Kimak MA, Lawrence EC, Finegold DN.

Lymphat Res Biol. 2008;6(2):69-76. doi: 10.1089/lrb.2007.1022.

PMID:
18564921
21.

HGF and MET mutations in primary and secondary lymphedema.

Finegold DN, Schacht V, Kimak MA, Lawrence EC, Foeldi E, Karlsson JM, Baty CJ, Ferrell RE.

Lymphat Res Biol. 2008;6(2):65-8. doi: 10.1089/lrb.2008.1524.

22.

Research perspectives in inherited lymphatic disease: an update.

Ferrell RE, Finegold DN.

Ann N Y Acad Sci. 2008;1131:134-9. doi: 10.1196/annals.1413.012. Review.

PMID:
18519966
23.

Predicting scoliosis progression from skeletal maturity: a simplified classification during adolescence.

Sanders JO, Khoury JG, Kishan S, Browne RH, Mooney JF 3rd, Arnold KD, McConnell SJ, Bauman JA, Finegold DN.

J Bone Joint Surg Am. 2008 Mar;90(3):540-53. doi: 10.2106/JBJS.G.00004.

PMID:
18310704
24.

Progress in developing polymerized crystalline colloidal array sensors for point-of-care detection of myocardial ischemia.

Baca JT, Finegold DN, Asher SA.

Analyst. 2008 Mar;133(3):385-90. doi: 10.1039/b712482a. Epub 2008 Jan 18.

PMID:
18299754
25.

Giving patients a say: how to work with patient advocacy groups.

Winkler AL, Finegold D.

Nat Biotechnol. 2008 Jan;26(1):23-6. No abstract available.

PMID:
18251047
26.

Tear glucose analysis for the noninvasive detection and monitoring of diabetes mellitus.

Baca JT, Finegold DN, Asher SA.

Ocul Surf. 2007 Oct;5(4):280-93. Review.

PMID:
17938838
27.

Potential misdiagnosis of 3-methylcrotonyl-coenzyme A carboxylase deficiency associated with absent or trace urinary 3-methylcrotonylglycine.

Wolfe LA, Finegold DN, Vockley J, Walters N, Chambaz C, Suormala T, Koch HG, Matern D, Barshop BA, Cropcho LJ, Baumgartner MR, Gibson KM.

Pediatrics. 2007 Nov;120(5):e1335-40. Epub 2007 Oct 1.

PMID:
17908719
28.

Mass spectral determination of fasting tear glucose concentrations in nondiabetic volunteers.

Baca JT, Taormina CR, Feingold E, Finegold DN, Grabowski JJ, Asher SA.

Clin Chem. 2007 Jul;53(7):1370-2. Epub 2007 May 10.

29.

Maturity assessment and curve progression in girls with idiopathic scoliosis.

Sanders JO, Browne RH, McConnell SJ, Margraf SA, Cooney TE, Finegold DN.

J Bone Joint Surg Am. 2007 Jan;89(1):64-73.

PMID:
17200312
30.

Analysis of tear glucose concentration with electrospray ionization mass spectrometry.

Taormina CR, Baca JT, Asher SA, Grabowski JJ, Finegold DN.

J Am Soc Mass Spectrom. 2007 Feb;18(2):332-6. Epub 2006 Nov 2.

31.

Correlates of the peak height velocity in girls with idiopathic scoliosis.

Sanders JO, Browne RH, Cooney TE, Finegold DN, McConnell SJ, Margraf SA.

Spine (Phila Pa 1976). 2006 Sep 15;31(20):2289-95.

PMID:
16985455
32.

Progress toward the development of a point-of-care photonic crystal ammonia sensor.

Kimble KW, Walker JP, Finegold DN, Asher SA.

Anal Bioanal Chem. 2006 Jun;385(4):678-85. Epub 2006 May 5.

PMID:
16741766
33.

Lessons on ethical decision making from the bioscience industry.

Mackie JE, Taylor AD, Finegold DL, Daar AS, Singer PA.

PLoS Med. 2006 May;3(5):e129. Epub 2006 Apr 4. No abstract available.

34.

Ethical decision-making in bioscience firms.

Finegold D, Moser A.

Nat Biotechnol. 2006 Mar;24(3):285-90. No abstract available.

PMID:
16525391
35.

Elective liver transplantation for the treatment of classical maple syrup urine disease.

Strauss KA, Mazariegos GV, Sindhi R, Squires R, Finegold DN, Vockley G, Robinson DL, Hendrickson C, Virji M, Cropcho L, Puffenberger EG, McGhee W, Seward LM, Morton DH.

Am J Transplant. 2006 Mar;6(3):557-64.

36.

How to conduct competitive intelligence in your biotech startup.

Finegold D, Carlucci S, Page A.

Nat Biotechnol. 2005 Jun;23(6):651-3. No abstract available.

PMID:
16044490
37.

The role of competitive intelligence in biotech startups.

Carlucci S, Page A, Finegold D.

Nat Biotechnol. 2005 May;23(5):525-7. No abstract available.

PMID:
15942983
38.

Alternative career options in the biomedical industry: the professional science master's degree.

Finegold D.

Nat Biotechnol. 2005 Apr;23(4):503-4. No abstract available.

PMID:
15815680
39.

Photonic crystal glucose-sensing material for noninvasive monitoring of glucose in tear fluid.

Alexeev VL, Das S, Finegold DN, Asher SA.

Clin Chem. 2004 Dec;50(12):2353-60. Epub 2004 Sep 30.

40.

Defective valves and abnormal mural cell recruitment underlie lymphatic vascular failure in lymphedema distichiasis.

Petrova TV, Karpanen T, Norrmén C, Mellor R, Tamakoshi T, Finegold D, Ferrell R, Kerjaschki D, Mortimer P, Ylä-Herttuala S, Miura N, Alitalo K.

Nat Med. 2004 Sep;10(9):974-81. Epub 2004 Aug 22.

PMID:
15322537
41.

Genetic and environmental influences on thyroid hormone variation in Mexican Americans.

Samollow PB, Perez G, Kammerer CM, Finegold D, Zwartjes PW, Havill LM, Comuzzie AG, Mahaney MC, Göring HH, Blangero J, Foley TP, Barmada MM.

J Clin Endocrinol Metab. 2004 Jul;89(7):3276-84.

PMID:
15240603
42.

Results of growth trophic therapy in children with short bowel syndrome.

Nucci AM, Finegold DN, Yaworski JA, Kowalski L, Barksdale EM Jr.

J Pediatr Surg. 2004 Mar;39(3):335-9; discussion 335-9.

PMID:
15017548
43.

A general photonic crystal sensing motif: creatinine in bodily fluids.

Sharma AC, Jana T, Kesavamoorthy R, Shi L, Virji MA, Finegold DN, Asher SA.

J Am Chem Soc. 2004 Mar 10;126(9):2971-7.

PMID:
14995215
44.

A genome-wide scan for loci affecting normal adult height in the Framingham Heart Study.

Mukhopadhyay N, Finegold DN, Larson MG, Cupples LA, Myers RH, Weeks DE.

Hum Hered. 2003;55(4):191-201.

PMID:
14566097
45.

High ionic strength glucose-sensing photonic crystal.

Alexeev VL, Sharma AC, Goponenko AV, Das S, Lednev IK, Wilcox CS, Finegold DN, Asher SA.

Anal Chem. 2003 May 15;75(10):2316-23.

PMID:
12918972
46.

African American hypertensive nephropathy maps to a new locus on chromosome 9q31-q32.

Chung KW, Ferrell RE, Ellis D, Barmada M, Moritz M, Finegold DN, Jaffe R, Vats A.

Am J Hum Genet. 2003 Aug;73(2):420-9. Epub 2003 Jul 1.

47.

Age of onset in hereditary lymphedema.

Levinson KL, Feingold E, Ferrell RE, Glover TW, Traboulsi EI, Finegold DN.

J Pediatr. 2003 Jun;142(6):704-8.

PMID:
12838201
48.

Autosomal dominant progressive nephropathy with deafness: linkage to a new locus on chromosome 11q24.

Prakash S, Chung KW, Sinha S, Barmada M, Ellis D, Ferrell RE, Finegold DN, Randhawa PS, Dinda A, Vats A.

J Am Soc Nephrol. 2003 Jul;14(7):1794-803.

49.

Maternal and fetal amino acid concentrations and fetal outcomes during pre-eclampsia.

Evans RW, Powers RW, Ness RB, Cropcho LJ, Daftary AR, Harger GF, Vergona R, Finegold DN.

Reproduction. 2003 Jun;125(6):785-90.

50.

Photonic crystal carbohydrate sensors: low ionic strength sugar sensing.

Asher SA, Alexeev VL, Goponenko AV, Sharma AC, Lednev IK, Wilcox CS, Finegold DN.

J Am Chem Soc. 2003 Mar 19;125(11):3322-9.

PMID:
12630888

Supplemental Content

Loading ...
Support Center